A nonapeptide encoded by human gene MAGE-1 is recognized on HLA-A1 by cytolytic T lymphocytes directed against tumor antigen MZ2-E
about
Identification of a SART-1-derived peptide capable of inducing HLA-A24-restricted and tumor-specific cytotoxic T lymphocytesA new family of genes coding for an antigen recognized by autologous cytolytic T lymphocytes on a human melanomaCloning of the gene coding for a shared human melanoma antigen recognized by autologous T cells infiltrating into tumorIdentification of the MAGE-1 gene product by monoclonal and polyclonal antibodiesA gene encoding antigenic peptides of human squamous cell carcinoma recognized by cytotoxic T lymphocytesAntigen processing in vivo and the elicitation of primary CTL responsesHuman tumor antigens recognized by T lymphocytesHuman gene MAGE-3 codes for an antigen recognized on a melanoma by autologous cytolytic T lymphocytesPhase I clinical study of anti-apoptosis protein, survivin-derived peptide vaccine therapy for patients with advanced or recurrent colorectal cancerImmunotherapy in gastric cancerCancer vaccinesExpression of tumor-rejection antigens in gynecologic cancersCytokines required for induction of histocompatibility leukocyte antigen-class I-restricted and tumor-specific cytotoxic T lymphocytes by a SART1-derived peptideUrinary benzene biomarkers and DNA methylation in Bulgarian petrochemical workers: study findings and comparison of linear and beta regression modelsPhotodynamic therapy of tumors can lead to development of systemic antigen-specific immune responseMelanoma Peptide Vaccines.Immunologic hierarchy, class II MHC promiscuity, and epitope spreading of a melanoma helper peptide vaccine.Isolation and characterization of a MAGE gene family in the Xp21.3 regionEvaluation of the sentinel immunized node for immune monitoring of cancer vaccinesAn HLA-A2-restricted tyrosinase antigen on melanoma cells results from posttranslational modification and suggests a novel pathway for processing of membrane proteinsIdentification of cyclin B1 as a shared human epithelial tumor-associated antigen recognized by T cells.Tumor antigens and tumor vaccines: peptides as immunogens.CT45A1 acts as a new proto-oncogene to trigger tumorigenesis and cancer metastasis.Murine leukemia RL male 1 and sarcoma Meth A antigens recognized by cytotoxic T lymphocytes (CTL).Clinical implications of the new biology in the development of melanoma vaccines.HLA-A*01:03, HLA-A*24:02, HLA-B*08:01, HLA-B*27:05, HLA-B*35:01, HLA-B*44:02, and HLA-C*07:01 monochain transgenic/H-2 class I null mice: novel versatile preclinical models of human T cell responses.Human tumor antigens for cancer vaccine development.Monitoring of antigen-specific cytolytic T lymphocytes in cancer patients receiving immunotherapyInduction of antigen-specific cytolytic T cells in situ in human melanoma by immunization with synthetic peptide-pulsed autologous antigen presenting cellsDirect evidence to support the immunosurveillance concept in a human regressive melanoma.Progress on new vaccine strategies for the immunotherapy and prevention of cancer.Immune responses to tumour antigens: implications for antigen specific immunotherapy of cancer.HLA photoaffinity labeling reveals overlapping binding of homologous melanoma-associated gene peptides by HLA-A1, HLA-A29, and HLA-B44.Human cell-based artificial antigen-presenting cells for cancer immunotherapy.Immune response after photodynamic therapy increases anti-cancer and anti-bacterial effects.Translating tumor antigens into cancer vaccinesThe MAGE proteins: emerging roles in cell cycle progression, apoptosis, and neurogenetic disease.Peptide vaccines for cancer.Cancer/testis antigens: structural and immunobiological properties.Immunotherapy for melanoma.
P2860
Q22009435-97E27F80-4054-4F31-A3CC-8FD980F1F74BQ24307739-EFC0F7ED-14F3-47FE-BFEE-B8A961D6BFC4Q24312048-79E32841-F580-4FE8-A85C-9BE59F6B9F25Q24563990-6D919DF7-7869-4F7B-BE39-2E903968F48FQ24647420-CFFF6241-FAD3-4545-8B1D-EAC64A16546CQ24675502-CE62EDC1-946A-4FE6-A749-0D6AC32AEC18Q24678508-B4184967-6C0A-45A7-817F-BA1852A5B923Q24680097-31E28043-D62D-4031-A6F2-CAC393A4AD32Q24801232-1748C63C-5A20-4F4C-9EEE-506FD010039CQ27010472-5DC1DA37-71E4-4657-AB07-1F8178C45CE3Q27024438-C66166E5-F9DA-4884-A751-21A640871BABQ28138549-F8D5F911-02F3-4042-B85B-FAC42F31058CQ28146219-6C7DF09D-B259-48ED-851E-8164E59DC1F7Q28391757-0A9F09EC-D3AE-49F2-9E45-03E5FFCCCBA5Q28744245-34DBBF8A-65D5-493D-9C9E-D2A0CE6FEFB5Q30305778-00D7D653-E903-41DA-8D87-AAFBED48D329Q30371547-F940C68D-D885-4DC6-80EF-7D1ADB316D63Q30418464-D21E884F-3D72-444C-A70F-217103AC7B76Q30433911-5B892588-D9CF-48C4-94C4-0239877EDA13Q30442847-AB8779B1-B562-4A5B-AEA1-99732190E4C4Q30442906-D57B7CA7-E220-4F42-9175-5223F9E9B0C8Q30469630-06A8EC63-9C9D-49C7-8415-657BCAF10BF9Q30829189-8430AD88-C803-4DEE-922B-814F922D18CCQ31023643-E09B7B8E-C0B9-4B8B-85D9-669D6C11BB47Q33603062-2E17A765-3365-434C-8933-664A3EE3932AQ33755226-5BE5939F-21BA-4A87-A706-E9E39D2DB461Q33776127-57A2C603-5CBE-4C50-9B83-63223F89308FQ33911899-B00907B7-4FAC-4E9C-8671-C83903117380Q34029001-69A2A2EE-0DB5-4F79-81F6-5729885B2630Q34137693-01D5E85A-5467-474D-B6C1-46B8CF1A74A4Q34328457-4A7BFFA9-9B22-43A2-A530-E4106B6E040FQ34353878-F522B264-BD48-4F88-ACC3-DA5B24EC3CD7Q34382215-51AA7C01-D939-474D-991F-D46109001360Q34391263-9B59E666-B32B-444C-8D92-2DC0AE543913Q34429312-0DB4B312-2BB8-4682-90A5-BD03BA6F59D9Q34484042-8DC1BCCD-4A39-46F0-BB9E-FDA0B7B0DD1CQ34561533-DB413894-101F-43B0-9310-AD33EDEE96CEQ34568992-A069F35E-095D-40EA-95E8-C14D0C1D8670Q34568997-FF028088-0080-494A-AFE7-FC82C5E98877Q34573035-21241D09-6609-4B7E-B524-36D0D29798F0
P2860
A nonapeptide encoded by human gene MAGE-1 is recognized on HLA-A1 by cytolytic T lymphocytes directed against tumor antigen MZ2-E
description
1992 nî lūn-bûn
@nan
1992年の論文
@ja
1992年論文
@yue
1992年論文
@zh-hant
1992年論文
@zh-hk
1992年論文
@zh-mo
1992年論文
@zh-tw
1992年论文
@wuu
1992年论文
@zh
1992年论文
@zh-cn
name
A nonapeptide encoded by human ...... ed against tumor antigen MZ2-E
@en
A nonapeptide encoded by human ...... ed against tumor antigen MZ2-E
@nl
type
label
A nonapeptide encoded by human ...... ed against tumor antigen MZ2-E
@en
A nonapeptide encoded by human ...... ed against tumor antigen MZ2-E
@nl
prefLabel
A nonapeptide encoded by human ...... ed against tumor antigen MZ2-E
@en
A nonapeptide encoded by human ...... ed against tumor antigen MZ2-E
@nl
P2093
P2860
P356
P1476
A nonapeptide encoded by human ...... ed against tumor antigen MZ2-E
@en
P2093
Amar-Costesec A
De Plaen E
Luescher IF
Traversari C
van der Bruggen P
P2860
P304
P356
10.1084/JEM.176.5.1453
P407
P577
1992-11-01T00:00:00Z